Figure 2.
ANA titers in patients with AHA and controls. Histogramof HEp-2 immunofluorescent ANA titers of patients with AHA (n = 69) compared with matched control patients (n = 69). Only nuclear patterns were considered.
ANA titers in patients with AHA and controls. Histogramof HEp-2 immunofluorescent ANA titers of patients with AHA (n = 69) compared with matched control patients (n = 69). Only nuclear patterns were considered.
